Affordable Access

Publisher Website

Deacylcortivazol acts through glucocorticoid receptors

Authors
Journal
Journal of Steroid Biochemistry
0022-4731
Publisher
Elsevier
Publication Date
Volume
14
Issue
3
Identifiers
DOI: 10.1016/0022-4731(81)90136-9

Abstract

Abstract Deacylcortivazol contains a phenyl-pyrazole moiety fused to the 2–3 position of the basic glucocorticoid steroid nucleus. When incubated with the glucocorticoid sensitive human leukemic cell line CEM-C7 it was found to be 20–50 times more cytotoxic than dexamethasone. In the same cell line it was 25-fold more active than dexamethasone in the induction of glutamine synthetase. Using a whole cell binding assay to measure competition for glucocorticoid receptors deacylcortivazol was found to be 17 times more effective than dexamethasone in competing with [ 3H]-dexamethasone for binding to receptor. When clones selected for resistance to 10 −6M dexamethasone and containing defective glucocorticoid receptors were treated with deacylcortivazol, no effect on cell growth or glutamine synthetase activity was observed, demonstrating a common pathway for the two steroids.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Deacylcortivazol acts through glucocorticoid recep...

on Journal of steroid biochemistr... March 1981

Glucocorticoid acts on a putative G protein-couple...

on AJP Endocrinology and Metaboli... Apr 01, 2012

Caffeine acts through neuronal adenosine A2A recep...

on Proceedings of the National Ac... Jun 23, 2015

Evidence that androgen acts through NMDA receptors...

on Journal of Neuroscience Nov 01, 2002
More articles like this..